Efficacy and Safety Study of the Fixed-dose Combination of Olmesartan + Indapamide When Compared to the Isolated Drugs in the Treatment of Hypertension.
Condition(s):Hypertension; Hypertension,EssentialLast Updated:March 21, 2022Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Hypertension; Hypertension,EssentialLast Updated:March 21, 2022Not yet recruiting
Condition(s):Multiple Sclerosis, Secondary ProgressiveLast Updated:May 18, 2022Recruiting
Condition(s):PharmacogenomicsLast Updated:March 24, 2022Not yet recruiting
Condition(s):Bioequivalence; Healthy SubjectsLast Updated:July 19, 2022Completed
Condition(s):HypertensionLast Updated:December 8, 2021Recruiting
Condition(s):Hypertension; Renal InsufficiencyLast Updated:June 24, 2014Completed
Condition(s):Bioequivalence; Healthy SubjectsLast Updated:July 22, 2022Completed
Condition(s):Hypertension; Type 2 Diabetes MellitusLast Updated:June 15, 2011Completed
Condition(s):HypertensionLast Updated:December 3, 2019Unknown status
Condition(s):Diabetes Mellitus, Type 2; HypertensionLast Updated:November 20, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.